We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$569M
AUM Growth
+$24.9M
Cap. Flow
+$4.65M
Cap. Flow %
0.82%
Top 10 Hldgs %
76.53%
Holding
95
New
18
Increased
30
Reduced
25
Closed
15

Sector Composition

1 Healthcare 11.07%
2 Financials 11.05%
3 Communication Services 5.29%
4 Industrials 2.44%
5 Technology 2.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$220M 38.62%
750,000
-70,000
-9% -$20.2M
IEF icon
2
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$95.3M 16.74%
865,800
ATH
3
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$23.9M 4.19%
553,921
MS icon
4
Morgan Stanley
MS
$339B
$19.1M 3.35%
434,820
+74
+0% +$3.3K
XLF icon
5
PUT
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
$15.2M 2.67%
+550,000
New +$14.9M
JPM icon
6
JPMorgan Chase
JPM
$907B
$13.2M 2.32%
117,971
+111
+0.1% +$12.2K
QQQ icon
7
PUT
Invesco QQQ Trust
QQQ
$466B
$12.6M 2.22%
+67,500
New +$12.4M
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.22T
$12.4M 2.18%
230,000
XBI icon
9
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$12.3M 2.16%
+140,000
New +$11.9M
DAL icon
10
Delta Air Lines
DAL
$55.4B
$11.9M 2.09%
210,000
COR icon
11
Cencora
COR
$59.9B
$10.7M 1.87%
125,000
+37,500
+43% +$2.97M
CVS icon
12
CVS Health
CVS
$137B
$10.5M 1.84%
192,571
+9,784
+5% +$527K
ZBH icon
13
Zimmer Biomet
ZBH
$17.6B
$9.98M 1.75%
87,289
+5,091
+6% +$596K
DVA icon
14
DaVita
DVA
$15.2B
$8.44M 1.48%
150,000
+75,000
+100% +$3.89M
BERY
15
DELISTED
Berry Global Group, Inc.
BERY
$7.89M 1.39%
163,348
-108,902
-40% -$5.25M
ZVRA icon
16
Zevra Therapeutics
ZVRA
$755M
$7.17M 1.26%
255,995
PARA
17
DELISTED
Paramount Global Class B
PARA
$6.99M 1.23%
140,000
-25,000
-15% -$1.24M
WBD icon
18
Warner Bros
WBD
$67.4B
$5.99M 1.05%
+195,000
New +$5.67M
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
$5.89M 1.04%
45,000
FOMX
20
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$5.55M 0.97%
2,330,400
+392,676
+20% +$1.17M
CINF icon
21
PUT
Cincinnati Financial
CINF
$28B
$4.15M 0.73%
+40,000
New +$3.84M
AGN
22
CALL
DELISTED
Allergan plc
AGN
$3.35M 0.59%
+20,000
New +$2.77M
AGN
23
DELISTED
Allergan plc
AGN
$3.35M 0.59%
+20,000
New +$2.77M
DFS
24
DELISTED
Discover Financial Services
DFS
$2.95M 0.52%
38,000
SMH icon
25
PUT
VanEck Semiconductor ETF
SMH
$67.5B
$2.75M 0.48%
+50,000
New +$2.72M

Similar funds

DSC Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, DSC Advisors held 95 positions worth $569M, up 4.6% from $544M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

DSC Advisors's Q2 2019 filing shows 18 new, 30 increased, 25 reduced and 15 closed positions. Its largest new stake was Warner Bros: 195,000 shares worth $5.99M. The largest sale was Berry Global Group, Inc., an estimated $5.25M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Financials and Communication Services.

  • DSC Advisors's largest Q2 2019 buy was Warner Bros: 195,000 shares worth $5.99M.
  • DSC Advisors added most to DaVita in Q2 2019, an estimated $3.89M increase.
  • DSC Advisors's biggest Q2 2019 reduction was Berry Global Group, Inc., cutting an estimated $5.25M.
  • DSC Advisors fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2019, selling an estimated $1.53M.
  • DSC Advisors's ten largest holdings make up 77% of its $569M portfolio in Q2 2019.
  • DSC Advisors opened 18 new positions and closed 15 in Q2 2019.
  • DSC Advisors's portfolio value rose 4.6% quarter-over-quarter to $569M.

Based on DSC Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.